Concepedia

Chris Dvergsten

CD

5

Publications

394

Citations

5

H-Index

1987

Active since

Affiliations

INC Research (United States)(Current)

Chris Dvergsten is an author at INC Research (United States) specializing in medicine, pain management, and health sciences.

Top concepts

Publications per year

1987–2021

5

Publications

5

Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study

M. Hale, Chris Dvergsten, Joseph Gimbel · Journal of Pain · 2004 · 154 citations

, , +7

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

David P. Walling, Stephen R. Marder, John M. Kane et al. · Schizophrenia Bulletin · 2015 · 96 citations · Full text

Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study

Nashat Gabrail, Chris Dvergsten, Harry Ahdieh · Current Medical Research and Opinion · 2004 · 79 citations

The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes

Klara R. Klein, Jennifer L. R. Freeman, Imogene Dunn et al. · Diabetes Care · 2021 · 39 citations · Full text

TRIPHENYL PHOSPHITE NEUROPATHY DIFFERS FROM ORGANOPHOSPHORUS‐INDUCED DELAYED NEUROPATHY IN RATS

Bellina Veronesi, Chris Dvergsten · Neuropathology and Applied Neurobiology · 1987 · 26 citations

Rows per page

1–5 of 5